The Oregon Health Authority (OHA) recently closed the first batch of administrative regulations regarding psilocybin products, testing and training programs. These rules will go into effect January 2023, when the State’s therapeutic psilocybin program authorized by the Oregon Psilocybin Services Act commences.
The state published a first draft of proposed psilocybin product, testing, and training directives earlier this year before soliciting feedback from its citizens in April. Over 200 written and verbal comments were submitted. People’s concerns pertained to three main issues: affordability, variety and accessibility.
Associated Production Costs
As Psychedelic Spotlight previously noted, this first legal draft raised significant affordability concerns. While the Oregon Psilocybin Services (OPS) acknowledged them, there was ultimately no resulting rule change. The letter the entity sent last week naming the finalized rules and outlining the amended ones further explained: “While creating access to services is a priority, OPS does not have statutory authority to regulate the costs of psilocybin products or psilocybin services. Because OPS is a fee-based program, the cost of administering the section’s work must be covered by licensing and application fees.”
